Oxidative stress levels in exhaled breath condensate associated with COPD and smoking

Respiratory Care

Volumn 57, Issue 3, 2012, Pages 413-419

  Inonu, Handan ^a   Doruk, Sibel ^a   Sahin, Semsettin ^a   Erkorkmaz, Unal ^a   Celik, Deniz ^a   Celikel, Serhat ^a   Seyfikli, Zehra ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

8 isoprostane; Hydrogen peroxide; Malondialdehyde; Oxidative stress; Smoking

Indexed keywords

8 ISOPROSTANE; CIGARETTE SMOKE CONDENSATE; HYDROGEN PEROXIDE; MALONALDEHYDE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EXHALATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT ASSESSMENT; RISK FACTOR; SMOKING HABIT; AGED; BREATH ANALYSIS; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; SMOKING;

AGED; BREATH TESTS; DINOPROST; HUMANS; HYDROGEN PEROXIDE; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 84859496120     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01302     Document Type: Article

References (29)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD report, updated December 2011 http://www.goldcopd.org/guidelines-global-strategy for-diagnosis-management.html. Accessed December 30, 2011.
2. Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin Chest Med 2000;21(1):67-86.
3. Rahman I, W MacNee. Role of oxidants/antioxidants in smokinginduced lung diseases. Free Radic Biol Med 1996;21:669-681.
4. Church T, WA Pryor. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-126.
5. Mak JC. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis 2008;12(4):368-374.
6. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 2005;4(3):175-200.
7. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary diseases. Am J Respir Crit Care Med 2001;163(7):1693-1722.
8. Romieu I, Barraza-Villarreal A, Escamilla-Nun ̃ez C, Almstrand AC, Diaz-Sanchez D, Sly PD, Olin AC. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol 2008;121(4):903-909.
9. Pryor WA, K Stone. Oxidants in cigarette smoke: radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993; 686:12-28.
10. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Khari-tonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162(3 Pt 1):1175-1177.
11. Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001;360(1-2):1-17.
12. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15(4):129-135.
13. Global Initiative for Chronic Obstructive Pulmonary Disease. 2001 original: pocket guide to COPD diagnosis, management, and prevention. Developed from the NHLBI/WHO Workshop Report, global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/Guidelines/guideline-2001-original%3apocket-guide-to-copd-diagnosis%2c-management%2c-andprevention.html. Accessed December 30, 2011.
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;16(Suppl):5-40.
15. Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. ATS/ERS Task Force. Eur Respir J 2005; 26(3):523-548.
16. Valenca SS, Silva Bezerra F, Lopes AA, Romana-Souza B, Marinho Cavalcante MC, Lima AB, et al. Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide. Environ Res 2008;108(2):199-204.
17. Borrill ZL, Roy K, Vessey RS, Woodcock AA, Singh D. Non-invasive biomarkers and pulmonary function in smokers. Int J Chron Obstruct Pulmon Dis 2008;3(1):171-183.
18. Pinamonti S, Muzzoli M, Chicca MC, Papi A, Ravenna F, Fabbri LM, Ciaccia A. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 1996;21(2):147-155.
19. Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, Tzanakis N. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2008;75(2):138-144.
20. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165(10):1364-1370.
21. Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med 2001;164(6):1012-1015.
22. van Beurden WJ, Harff A, Dekhuijzen PN, van der Poel-Smet SM, Smeenk FW. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003;70(3):242-248.
23. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996;153(2):616-621.
24. Stockley RA, Morrison HM, Kramps JA, Dijkman JH, Burnett D. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophils elastase inhibition, and effect of corticosteroids treatment. Thorax 1986;41(6):442-447.
25. Goldstein IM, Roos D, Kaplan HB. Influence of corticosteroids on human polymorphonuclear leukocytes function in vitro. Inflamma-tion 1976;1:305-315.
26. van der Vaart H, Postma DS, Timens W, Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004;59(8):713-721.
27. Nowak D, Kalucka S, Bialasiewicz P, Król M. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001;30(2):178-186.
28. Bloomer RJ. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake. Nutr J 2007;39:1-6.
29. Corradi M, Rubinstein I, Andreoli R, Manini P, Caglieri A, Poli D, et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(10):1380-1386.